Performance enhancement drugs: what they are, what they do, and what they cost

“Performance enhancement drugs” is a phrase that gets thrown around like it means one thing. It doesn’t. In clinic, I hear it used to describe everything from prescription medicines that restore normal function to underground “stacks” sold online with labels that read like science fiction. The same two words can refer to a legitimate therapy for a diagnosed condition—or to a risky experiment on a healthy body that was doing fine until someone decided it needed an upgrade.

That ambiguity matters, because the medical reality is messy. Some drugs that improve performance in one domain (say, breathing or attention) can worsen performance somewhere else (sleep, mood, blood pressure, fertility). Patients tell me they expected a clean trade: “more energy, more strength, more focus.” The human body rarely bargains that neatly. Side effects, interactions, and underlying health issues tend to show up right when you least want them.

This article takes a practical, evidence-based look at performance enhancement drugs: what counts as “performance,” which substances have real medical indications, what is known about benefits and harms, and where myths keep outrunning facts. We’ll also talk about the social and market forces that shape use—counterfeits, online sales, and the way “biohacking” culture borrows medical language while skipping medical safeguards. If you want a deeper primer on medication safety basics, see our guide to drug interactions and contraindications.

One more framing point before we start: “performance enhancement” is not a therapeutic class. It’s a goal. The drugs involved span multiple pharmacological classes, including anabolic-androgenic steroids (AAS), sympathomimetic stimulants, beta-2 agonists, erythropoiesis-stimulating agents (ESAs), phosphodiesterase-5 (PDE5) inhibitors, and others. Some are approved for specific diseases. Others are diverted from medical use. A few are outright illicit. The details matter.

1) Medical applications

When clinicians prescribe a drug that improves “performance,” the intent is usually to restore function that has been limited by disease. That’s a very different ethical and medical landscape than boosting a healthy person beyond baseline. I often see the two get blended together online, and the result is confusion—and sometimes harm.

2.1 Primary indication: treating diagnosed conditions that impair function

There is no single primary indication for “performance enhancement drugs” because the term covers many medications. In medical practice, the most defensible “primary use” is treatment of a diagnosed condition where improved performance is a downstream effect of treating pathology. A few common examples:

Testosterone (generic/international nonproprietary name: testosterone) for male hypogonadism (testosterone deficiency) when confirmed by symptoms and repeated lab testing. Therapeutic class: androgen. Brand names include AndroGel, Testim, Axiron, Depo-Testosterone, and others depending on formulation and region.
Albuterol/salbutamol (therapeutic class: short-acting beta-2 agonist) for asthma and bronchospasm. Better breathing can translate into better exercise tolerance, but the goal is airway control, not athletic advantage.
Methylphenidate and amphetamine salts (therapeutic class: central nervous system stimulants) for attention-deficit/hyperactivity disorder (ADHD). Brand names include Ritalin, Concerta, Adderall, and others. Improved attention is the target; “productivity enhancement” is not an approved indication.
Sildenafil (therapeutic class: PDE5 inhibitor) for erectile dysfunction and also for pulmonary arterial hypertension under different dosing and brand contexts. Brand names include Viagra and Revatio.

Notice what these have in common: a diagnosis, a defined therapeutic target, and a clinician monitoring for benefit and harm. Even then, expectations need to stay realistic. Testosterone therapy, for example, does not “turn back the clock” on aging, and it does not reliably transform mood, relationships, or motivation. Sildenafil improves erectile response when sexual stimulation is present; it does not create desire, and it does not fix relationship stress, depression, or vascular disease. Stimulants can improve ADHD symptoms, yet they can also worsen anxiety, insomnia, and blood pressure. I’ve watched patients learn that lesson the hard way.

In other words, medical use is about function and safety. Enhancement culture is about outcomes. Those are not the same thing.

2.2 Approved secondary uses (selected examples)

Several drugs that get pulled into “performance” conversations have legitimate secondary indications. These are not “loopholes.” They are separate, evidence-based uses with their own risk profiles.

Sildenafil (sildenafil citrate): beyond erectile dysfunction, sildenafil is used for pulmonary arterial hypertension (PAH) to improve exercise capacity by reducing pulmonary vascular resistance. That is a cardiopulmonary disease context, not a gym context.
Testosterone: depending on region and formulation, testosterone can be used in gender-affirming hormone therapy for transgender men and some nonbinary individuals under specialist care. The goal is alignment of physical characteristics with gender identity, with careful monitoring of hematocrit, lipids, and other parameters.
Beta-2 agonists: inhaled agents are used for asthma and COPD symptom relief. They can cause tremor and palpitations—hardly the “clean energy” people imagine when they borrow an inhaler before a workout.

Patients often ask me, “If it’s approved for something else, doesn’t that mean it’s safe?” Safe is not a property of a molecule in isolation. Safety is a relationship between a drug, a dose, a person’s physiology, and the rest of their medication list. That’s why clinicians keep circling back to history, exam, and labs. Boring, yes. Effective, also yes.

2.3 Off-label uses (where clinicians sometimes tread carefully)

Off-label prescribing is legal and common in medicine, but it’s not a free-for-all. It means a clinician uses a drug outside the exact wording of its regulatory label based on evidence, guidelines, and patient-specific reasoning.

In the performance sphere, off-label use often shows up as:

PDE5 inhibitors (such as sildenafil or tadalafil) used off-label for certain sexual performance concerns not strictly meeting erectile dysfunction criteria, or for medication-related sexual side effects. The evidence varies by scenario, and the cardiovascular screening still matters.
Stimulants used off-label for severe fatigue syndromes in select contexts. This is controversial, and the risk of dependence, anxiety, and sleep disruption is not theoretical.
Clonidine or propranolol used off-label for performance anxiety in specific situations. These are not “confidence pills.” They affect blood pressure, heart rate, and alertness, and they can backfire.

I often see people treat “off-label” as a synonym for “secretly better.” In practice, it usually means “we’re working with imperfect options.” That’s a very different vibe.

2.4 Experimental / emerging uses (and where the evidence is thin)

Every few months, a new compound gets marketed as the next leap in human performance: selective androgen receptor modulators (SARMs), peptide hormones, “research chemicals,” microdosing regimens, and more. The scientific reality is that many of these products have limited human data, inconsistent manufacturing quality, and unclear long-term safety.

Research continues in areas like muscle wasting disorders, anemia management, and novel treatments for sleep and cognition. That’s legitimate science. What’s not legitimate is skipping from “early signal in a small study” to “guaranteed gains with no downside.” On a daily basis I notice how quickly that leap happens on social media, especially when a supplement store or affiliate link is involved.

For readers interested in the broader landscape of health misinformation online, our overview of how to evaluate medical claims on the internet is a useful companion.

3) Risks and side effects

Risk is the part of the conversation that gets edited out of marketing. Even when a drug is FDA-approved for a real condition, using it outside that context changes the risk-benefit equation. When the product is counterfeit or contaminated, you’re not even evaluating the right drug anymore.

3.1 Common side effects

Side effects depend on the specific substance, but several patterns show up repeatedly across performance enhancement drugs:

Anabolic-androgenic steroids / testosterone: acne, oily skin, hair loss in genetically susceptible individuals, mood changes, irritability, fluid retention, and changes in libido. People also report feeling “wired” or restless, which can wreck sleep.
Stimulants (methylphenidate, amphetamines): decreased appetite, dry mouth, insomnia, jitteriness, increased heart rate, and anxiety. The “laser focus” story is common; so is the crash.
PDE5 inhibitors (sildenafil, tadalafil): headache, facial flushing, nasal congestion, indigestion, and light sensitivity or visual color tinge. These are often transient, but they can be unpleasant.
Beta-2 agonists: tremor, palpitations, nervousness, and sometimes muscle cramps.

Many common effects are mild, but “mild” doesn’t mean “ignore it.” Patients tell me they kept pushing through insomnia or palpitations because the gym numbers looked good. That’s a classic setup for a bigger problem later.

3.2 Serious adverse effects

Serious harms are less common, but they are the reason clinicians get cautious. A few high-stakes examples:

Cardiovascular events: stimulants can raise blood pressure and heart rate; anabolic steroids can worsen lipids and contribute to hypertension; erythropoiesis-stimulating approaches can increase blood viscosity. In the wrong person, that combination is playing with fire.
Arrhythmias: palpitations are not always benign. If someone develops chest pain, fainting, severe shortness of breath, or a racing irregular heartbeat, that’s urgent.
Liver injury: certain oral anabolic steroids are associated with hepatotoxicity. I’ve seen lab panels where the liver enzymes tell the story long before the patient feels sick.
Psychiatric effects: anxiety, agitation, panic, and mood instability can occur with stimulants and with androgen misuse. The “I feel unstoppable” phase can slide into irritability or impulsivity.
Priapism (prolonged painful erection) is a rare emergency associated with PDE5 inhibitors and other agents affecting sexual function. It’s not a joke, and waiting it out can cause permanent damage.
Endocrine and reproductive harms: exogenous androgens can suppress the hypothalamic-pituitary-gonadal axis, leading to testicular atrophy and infertility. People are often shocked by how quickly this can happen.

If you take one thing from this section, let it be this: serious adverse effects are not reserved for “reckless” people. They can happen to disciplined, health-conscious users who simply underestimated physiology.

3.3 Contraindications and interactions

Contraindications and interactions vary by drug class, but several are common enough to deserve plain language.

PDE5 inhibitors (sildenafil, tadalafil) have a major interaction with nitrates (used for angina) and can cause dangerous drops in blood pressure. They also require caution with certain alpha-blockers and other blood pressure-lowering medications.
Stimulants interact with other sympathomimetics, certain antidepressants, and substances that raise heart rate and blood pressure. Combining them with high caffeine intake is a frequent real-world problem. People forget caffeine is a drug because it comes in a cup.
Anabolic steroids / testosterone can complicate conditions like prostate disease, polycythemia (elevated hematocrit), untreated severe sleep apnea, and certain cardiovascular risks. They also interact with anticoagulants and can affect glucose control.
Alcohol and recreational drugs add unpredictability: dehydration, impaired judgment, and additive cardiovascular strain. The “party + performance” combo is where I see the most avoidable emergencies.

Safety depends on the full picture: medical history, family history, current prescriptions, over-the-counter products, and supplements. If you want a structured way to think about this, our explainer on medication reconciliation walks through the concept without the hospital jargon.

4) Beyond medicine: misuse, myths, and public misconceptions

Misuse is not always driven by vanity. Sometimes it’s fear—fear of aging, fear of falling behind, fear of not being enough. I’ve had patients look me in the eye and say, “Everyone else is doing something.” Whether that’s true or not, the belief changes behavior.

4.1 Recreational or non-medical use

Non-medical use tends to cluster around a few goals: muscle gain, fat loss, endurance, sexual performance, and cognitive output. The substances vary—AAS, stimulants, PDE5 inhibitors, thyroid hormones, diuretics, insulin, peptides, and more. The common thread is self-directed dosing without medical monitoring, often sourced from informal markets.

Expectations are frequently inflated. People assume linear gains: more drug equals more performance. Biology doesn’t scale that way. Receptors downregulate, sleep deteriorates, appetite changes, injuries accumulate, and mental health can wobble. The irony is that the pursuit of “optimization” can degrade the very systems that support performance: recovery, mood stability, and cardiovascular resilience.

4.2 Unsafe combinations

Stacking is where risk multiplies. A stimulant plus a fat burner plus pre-workout caffeine plus a decongestant for a cold—then alcohol at night—creates a cardiovascular stress test no one asked for. Add an androgen cycle and you’ve layered lipid changes and blood pressure effects on top of sympathetic stimulation. I wish I were exaggerating; I’m not.

Another common risky pairing is PDE5 inhibitors with recreational vasodilators (“poppers”) or with nitrates. The blood pressure drop can be abrupt and severe. People chasing a better night out rarely plan for an ambulance ride.

4.3 Myths and misinformation

Myth: “If it’s a prescription drug, it’s safe for anyone.” Reality: prescription status means it has a defined medical use and known risks under supervision, not universal safety.
Myth: “Natural testosterone boosters are basically the same as testosterone.” Reality: most supplements do not raise testosterone meaningfully in healthy adults, and some contain undisclosed ingredients or contaminants.
Myth: “PDE5 inhibitors increase sexual desire.” Reality: they improve erectile physiology; desire is influenced by hormones, mood, relationship context, and overall health.
Myth: “Stimulants make you smarter.” Reality: they can increase wakefulness and focus, but they can also narrow attention, worsen anxiety, and impair sleep—often the opposite of what learning needs.
Myth: “Bloodwork looks fine, so the cycle is harmless.” Reality: labs are snapshots. Some harms are cumulative, and some risks (arrhythmia, clot, psychiatric destabilization) don’t announce themselves politely in a routine panel.

Want a quick reality check? Ask: “What would convince me I’m wrong?” If the answer is “nothing,” you’re not doing health science—you’re doing belief.

5) Mechanism of action (in plain but accurate terms)

Because performance enhancement drugs span many classes, the mechanisms differ. Still, most work through a few recurring biological levers: hormones, neurotransmitters, oxygen delivery, and vascular tone.

Hormonal pathways (anabolic-androgenic steroids and testosterone)

Testosterone and other anabolic-androgenic steroids bind to the androgen receptor inside cells. That receptor then influences gene transcription, shifting protein synthesis and tissue remodeling. In medical contexts like hypogonadism, restoring physiologic testosterone levels can improve sexual function, bone density, and anemia in selected patients. In non-medical contexts, supraphysiologic exposure can accelerate muscle hypertrophy, but it also disrupts the endocrine feedback loops that regulate fertility and natural hormone production.

The body is not impressed by your goals. It responds to signals. When the signal is excessive, it compensates—often in ways users don’t anticipate.

Neurotransmitters (stimulants)

Stimulants used for ADHD generally increase signaling in catecholamine pathways, especially dopamine and norepinephrine, in brain circuits involved in attention and executive function. That can improve task initiation and sustained focus in people with ADHD. In healthy individuals, the same shift can produce wakefulness and drive, but also anxiety, irritability, and insomnia. Sleep debt then erodes cognition, reaction time, and mood. I’ve watched that loop spiral: stimulant to work, poor sleep, more stimulant, worse sleep.

Vascular tone and blood flow (PDE5 inhibitors)

Sildenafil and related PDE5 inhibitors block the enzyme phosphodiesterase type 5, which breaks down cGMP. By preserving cGMP, these drugs enhance smooth muscle relaxation in certain vascular beds. In erectile tissue, that supports increased blood flow during sexual stimulation. In pulmonary arterial hypertension, the same pathway can reduce pulmonary vascular resistance. They do not “force” an erection in the absence of arousal, and they do not override severe vascular disease.

Oxygen delivery (ESAs and blood manipulation)

Erythropoiesis-stimulating agents act on the bone marrow to increase red blood cell production. In medicine, they are used in specific anemia contexts under strict monitoring. In sport misuse, the goal is endurance via higher oxygen-carrying capacity. The trade-off is thicker blood, higher clot risk, and cardiovascular strain—especially with dehydration or altitude exposure.

6) Historical journey

The history of performance enhancement drugs is basically the history of humans trying to out-negotiate biology. Sometimes that effort produced genuine medical breakthroughs. Other times it produced scandals, injuries, and a long trail of “miracle” products that quietly disappeared.

6.1 Discovery and development

Modern testosterone therapy traces back to early 20th-century endocrinology, when researchers isolated and synthesized androgens and began mapping their effects on sexual development, muscle, and metabolism. Over decades, pharmaceutical development produced multiple delivery systems—injectable esters, transdermal gels, patches—each with different pharmacokinetics and monitoring considerations.

Sildenafil’s story is a classic example of repurposing. It was investigated for cardiovascular indications, and its effect on erectile function became the headline. That pivot changed public conversation about erectile dysfunction, and it also created a huge market for “performance” narratives that often ignore cardiovascular screening.

Stimulants have an even longer arc, from early sympathomimetic compounds to modern ADHD pharmacotherapy. Their benefits in properly diagnosed ADHD are real. Their misuse in academic and workplace settings is also real. I’ve had college students describe it like borrowing time from tomorrow. That’s not far off.

6.2 Regulatory milestones

Regulatory approvals for these drugs generally followed evidence of benefit in defined diseases: hypogonadism for testosterone, erectile dysfunction and pulmonary arterial hypertension for sildenafil, ADHD for stimulants, and specific anemia indications for ESAs. Alongside approvals came safety warnings, post-marketing surveillance, and evolving prescribing guidance as real-world data accumulated.

In parallel, sports governing bodies developed anti-doping rules as misuse became widespread. That cat-and-mouse dynamic—new agents, new tests, new evasions—has shaped public perception. People often assume “banned” equals “works.” Sometimes it does. Sometimes it’s banned because it’s dangerous, or because it undermines fair competition, or both.

6.3 Market evolution and generics

As patents expired, generics expanded access for legitimate patients. Sildenafil is a clear example: generic availability reduced cost barriers in many settings, which is good for people with diagnosed conditions. At the same time, broader availability also increased casual use and online purchasing, including counterfeit products.

Testosterone markets have also evolved, with periodic surges in demand driven by cultural narratives about masculinity, aging, and “low T.” In my experience, the marketing language often outruns the medical criteria. That gap is where misdiagnosis and overtreatment can creep in.

7) Society, access, and real-world use

Performance enhancement drugs sit at an awkward intersection: medicine, identity, competition, and commerce. That intersection creates stigma for patients who need treatment and temptation for people who don’t. It also creates a thriving gray market.

7.1 Public awareness and stigma

Some conditions tied to “performance” are still hard for people to talk about. Erectile dysfunction, infertility, and low libido can feel like personal failure rather than health issues. I often see relief when patients realize they’re not alone and that vascular health, mental health, sleep, and medications can all play a role.

ADHD is another area where stigma cuts both ways. Some patients feel dismissed as “drug-seeking,” while others assume stimulants are harmless productivity tools. Both narratives miss the clinical nuance. Diagnosis and follow-up matter. So does sleep. Always sleep.

7.2 Counterfeit products and online pharmacy risks

Counterfeit performance drugs are a genuine public health problem. Products sold as “Viagra,” “Cialis,” “testosterone,” or “SARMs” can contain the wrong dose, the wrong drug, multiple drugs, or contaminants. Even when the label is accurate, storage and shipping conditions can degrade potency. People then compensate by taking more, which compounds risk.

Here’s what I tell friends when they ask, off the record, how to reduce harm: if a product bypasses the normal prescription and pharmacy safeguards, you lose quality control and accountability. That’s not moralizing; it’s logistics. If something goes wrong, no one can trace the supply chain, and your clinician is left guessing what you actually took.

7.3 Generic availability and affordability

Generics can be a win for access. A generic drug contains the same active ingredient (generic/international nonproprietary name) as the brand and must meet regulatory standards for quality and bioequivalence. For patients with erectile dysfunction or pulmonary arterial hypertension, generic sildenafil can reduce financial strain and improve adherence.

That said, affordability pressures also drive people toward unregulated sellers. The paradox is painful: the desire to save money can increase the chance of buying a counterfeit that costs far more in the long run.

7.4 Regional access models (OTC / prescription / pharmacist-led)

Access rules vary widely by country and sometimes change over time. Some regions allow pharmacist-led access to certain sexual health medications under protocols; others require a prescription and clinician evaluation. Testosterone is generally prescription-only because of endocrine effects and monitoring needs, but enforcement and availability differ across markets.

If you travel, don’t assume your home rules apply elsewhere. I’ve seen patients return with products purchased abroad that were mislabeled or dosed unpredictably. The packaging looked professional. The lab results later told a different story.

8) Conclusion

Performance enhancement drugs are not one drug, one mechanism, or one story. They include legitimate therapies—testosterone for confirmed hypogonadism, sildenafil for erectile dysfunction or pulmonary arterial hypertension, stimulants for ADHD—that can meaningfully improve quality of life when used for the right reasons under medical supervision. They also include a long list of misused or illicit substances sold on the promise of effortless gains.

The facts are less glamorous than the hype: benefits are context-dependent, risks are real, and stacking compounds increases unpredictability. The safest path is boring: accurate diagnosis, evidence-based treatment, and honest follow-up when side effects show up. Patients often want certainty. Medicine usually offers probabilities.

Informational disclaimer: This article is for general education and does not replace personalized medical advice, diagnosis, or treatment. If you are considering any performance-related drug or supplement—or you’re already using one—discuss it with a licensed healthcare professional who can review your medical history, medications, and risk factors.